3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Carcinoma, Non-Small-Cell Lung
9
Rhabdomyosarcoma
6
Triple Negative Breast Neoplasms
5
Hodgkin Disease
4
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Adenocarcinoma
2
Solitary Fibrous Tumor, Pleural
1
NSCLC
1
Metastatic HER2-positive Breast Cancer
1
Mesothelioma, Malignant
1
Lung Diseases, Interstitial
1
Locally Advanced Non-Small Cell Lung Cancer
1
HR+HER2- Breast Cancer
1
HER2-negative Metastatic Breast Cancer
1
Fludzoparib" and Anti-angiogenic
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Large Cell
1
Advanced Breast Cancer
1
Interventions
Paclitaxel
4
Cyclophosphamide
4
exemestane
3
Taxes
3
Tamoxifen
3
Letrozole
3
Doxorubicin
3
Anastrozole
3
Trastuzumab
2
Leuprolide
2
Immunotherapy
2
Goserelin
2
Carboplatin
2
trastuzumab biosimilar HLX02
1
ribociclib
1
pegfilgrastim
1
elacestrant
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abemaciclib
1
Vitamins
1
Standard of Care
1
Radiosurgery
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
PF-05280014
1
Ontruzant
1
Omeprazole
1
Ogivri
1
Neoadjuvant Therapy
1
Methods
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
Vinorelbine
×
1 year
×
Clear all
No trials found.